Puma Biotechnology director Michael Patrick Miller reports sale of $121,456.50 in common shares

PBYI•2026-11-14

Director Michael Patrick Miller sold 15,000 Puma Biotechnology shares on Nov. 11, 2026, at $8.0971 each, leaving him with 66,000 shares held directly.

1. Share sale

Michael Patrick Miller sold 15,000 shares of Puma Biotechnology common stock on Nov. 11, 2026, at $8.0971 per share. He held 66,000 shares directly after the sale.

Sources

Puma Biotechnology director Michael Patrick Miller reports sale of $121,456.50 in common shares

Sec

Puma Biotechnology director Michael Patrick Miller reports sale of $121,456.50 in common shares

1. Share sale

Related News

Kentucky Power seeks approval for 760-MW gas plant to serve TeraWulf data campus

Box CFO Dylan C. Smith reports sale of common shares worth $710,942.529

Nasdaq halts trading in TGL pending news at 8:00 p.m.

Sources

Puma Biotechnology director Michael Patrick Miller reports sale of $121,456.50 in common shares

Syntec Optics Q3 swings to net income of $246,574 as revenue rises 23% to $8.5 million

Adaptive Biotechnologies President and COO Julie Rubinstein sells $1.05 million in common shares